|

ALNYLAM PHARMACEUTICALS INC (ALNY)

US02043Q1076 - Common Stock

170.92  +0.88 (+0.52%)

After market: 170.92 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

MRQ
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
1.03B866.40M820.00M496.60M547.20M
Marketable Securities
1.37B1.33B1.62B1.38B989.00M
Receivables
325.40M238.00M198.60M602.40M43.00M
Inventories
95.80M129.00M86.40M75.20M56.30M
Other Current Assets
158.00M132.90M88.10M62.80M80.30M
Total Current Assets
2.99B2.69B2.81B2.61B1.72B
 
Non-Current Assets
PPE Net
729.10M738.60M733.60M706.50M646.40M
Investments And Advances
N/AN/AN/AN/AN/A
Other Non-Current Assets
124.50M115.50M101.10M85.80M32.90M
Total Non-Current Assets
853.60M854.20M834.70M792.30M679.20M
 
TOTAL ASSETS
3.84B3.55B3.64B3.41B2.40B
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
754.60M587.40M435.70M392.80M224.90M
Accounts Payable
73.80M98.10M73.40M52.00M49.90M
Other Current Liabilities
121.30M82.40M186.60M140.50M77.80M
Total Current Liabilities
949.80M767.90M695.70M585.30M352.60M
 
Non-Current Liabilities
Long Term Debt
1.02B1.02B675.70M191.30M0.00
Other Non-Current Liabilities
2.04B1.92B1.68B1.61B603.80M
Total Non-Current Liabilities
3.06B2.94B2.36B1.81B603.80M
 
TOTAL LIABILITIES
4.00B3.70B3.06B2.39B956.40M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-6.87B-6.57B-5.44B-4.59B-3.73B
Additional Paid In Capital
6.74B6.45B6.06B5.64B5.20B
Common Shares
1.30M1.20M1.20M1.20M1.10M
Other Shareholders' Equity
5.90M-2.40M1.20M-11.20M-3.90M
Shares Outstanding
125.50M123.90M120.20M116.40M112.20M
Tangible Book Value per Share
-1.32-1.284.898.7312.82
Total Shareholders' Equity
-165.90M-158.20M588.20M1.02B1.44B
 
TOTAL LIABILITIES AND EQUITY
3.84B3.55B3.64B3.41B2.40B
 
Statistics
Debt/Equity
-6.15-6.431.150.19N/A
Current Ratio
3.143.514.044.474.87
Return On Assets (ROA)
-13.28%-31.90%-23.41%-25.19%-37.00%
Return On Equity (ROE)
N/AN/A-144.98%-84.46%-61.59%

All data in USD

Charts